LGVN

SEC source: 0001214659-23-003461 · marketforms-59748.xml · nonDerivative · entry 1

Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: Represents the award of Restricted Stock Units, which vest 25% at the end of each calendar quarter in 2023.

F2 · balance_after: Includes 50,000 Restricted Stock Units.

SEC source: 0001214659-24-001811 · marketforms-64546.xml · derivative · entry 1

Hashad Mohamed Wa'el Ahmed · CIK 0001966752 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-03-01

SEC source: 0001214659-23-001282 · marketforms-58429.xml · nonDerivative · entry 1

Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,793,263

F1 · shares: Pursuant to a currently effective Rule 10b5-1 Plan.

F2 · price: The trade was executed in a series of transactions with a price range of $4.13 to $4.56, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Amount includes 7,632,902 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F4 · balance_after: Includes Restricted Stock Units subject to future vesting.

SEC source: 0001214659-23-000205 · marketforms-58084.xml · nonDerivative · entry 1

Clavijo James · CIK 0001306908 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,649

F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

SEC source: 0001214659-23-000206 · marketforms-58085.xml · nonDerivative · entry 1

Lehr Paul T · CIK 0001845674 · General Counsel, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,042

F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

SEC source: 0001214659-22-015251 · marketforms-57932.xml · derivative · entry 1

Ungaro Ursula · CIK 0001865511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant.

SEC source: 0001214659-22-015253 · marketforms-57926.xml · derivative · entry 1

Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant.

SEC source: 0001214659-22-015252 · marketforms-57928.xml · derivative · entry 1

LOSORDO DOUGLAS W · CIK 0001583810 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant.

SEC source: 0001214659-22-015257 · marketforms-57933.xml · derivative · entry 1

Borger Erin · CIK 0001845221 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant.

SEC source: 0001214659-22-015256 · marketforms-57927.xml · derivative · entry 1

Hare Neil E · CIK 0001845271 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant.

SEC source: 0001214659-22-015255 · marketforms-57931.xml · derivative · entry 1

Soffer Rock · CIK 0001845308 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant.

SEC source: 0001214659-22-015250 · marketforms-57930.xml · derivative · entry 1

Soffer Donald M · CIK 0001845860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant.

SEC source: 0001214659-22-015254 · marketforms-57929.xml · derivative · entry 1

Ross Cathy · CIK 0001845222 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant.

SEC source: 0001214659-22-015249 · marketforms-57533.xml · derivative · entry 1

Girolamo Todd C · CIK 0001891257 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-12-21

F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on first anniversary of date of grant.

SEC source: 0001214659-22-014532 · marketforms-57774.xml · nonDerivative · entry 1

Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,813,263

F1 · shares: Pursuant to a currently effective Rule 10b5-1 Plan.

F2 · price: The trade was executed in a series of transactions with a price range of $3.65 to $3.82, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Amount includes 7,652,902 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F4 · balance_after: Includes Restricted Stock Units subject to future vesting.

SEC source: 0001214659-22-014017 · marketforms-57585.xml · nonDerivative · entry 1

Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,861,403

F1 · shares: Restricted Stock Units, vesting in full on date of grant.

F2 · balance_after: Includes Restricted Stock Units subject to future vesting.

F3 · balance_after: Amount includes 7,672,902 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

SEC source: 0001214659-22-014018 · marketforms-57584.xml · derivative · entry 1

Lehr Paul T · CIK 0001845674 · General Counsel, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,843

Underlying: Common Stock · 22,843 shares

Expires 2032-11-16

F1 · derivative.exercise_date: The option vests 25% on March 1, 2023, and quarterly thereafter at the end of each calendar quarter, through March 30, 2026

SEC source: 0001214659-23-000715 · marketforms-58182.xml · nonDerivative · entry 1

Clavijo James · CIK 0001306908 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,649

SEC source: 0001214659-22-012423 · marketforms-57340.xml · nonDerivative · entry 1

Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,813,263

F1 · balance_after: Amount includes 7,672,902 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F2 · balance_after: Amount includes 10,780 restricted stock units subject to vesting.

SEC source: 0001214659-22-012063 · marketforms-57294.xml · nonDerivative · entry 1

Clavijo James · CIK 0001306908 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,937

F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

SEC source: 0001214659-22-012062 · marketforms-57295.xml · nonDerivative · entry 1

Lehr Paul T · CIK 0001845674 · General Counsel, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,514

F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

SEC source: 0001214659-22-008624 · marketforms-56618.xml · nonDerivative · entry 1

Clavijo James · CIK 0001306908 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,193

F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

SEC source: 0001214659-22-008626 · marketforms-56620.xml · nonDerivative · entry 1

Lehr Paul T · CIK 0001845674 · General Counsel, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,949

F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

SEC source: 0001214659-22-007877 · marketforms-56412.xml · nonDerivative · entry 2

Clavijo James · CIK 0001306908 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,619

F2 · price: Represents the weighted average of multiple open-market sales transactions ranging from $8.25 to $8.26. The reporting person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Company or a security holder of the Company.

SEC source: 0001214659-22-007877 · marketforms-56412.xml · nonDerivative · entry 1

Clavijo James · CIK 0001306908 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,574

F1 · shares: Time-based restricted stock units subject to vesting

SEC source: 0001214659-22-007878 · marketforms-56413.xml · derivative · entry 2

Lehr Paul T · CIK 0001845674 · General Counsel, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common stock · 5,000 shares

Expires 2032-06-03

F2 · derivative.exercise_date: Option vests 100% on date of grant.

SEC source: 0001214659-22-007878 · marketforms-56413.xml · nonDerivative · entry 1

Lehr Paul T · CIK 0001845674 · General Counsel, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,578

F1 · shares: Time-based restricted stock units subject to vesting

SEC source: 0001214659-22-007393 · marketforms-56325.xml · nonDerivative · entry 3

Soffer Rock · CIK 0001845308 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 672,351

F3 · balance_after: Share amounts include 640,098 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

SEC source: 0001214659-22-007393 · marketforms-56325.xml · nonDerivative · entry 2

Soffer Rock · CIK 0001845308 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 676,351

F2 · price: The trade was executed in a series of transactions with a price range of $7.70 to $7.80, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Share amounts include 640,098 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

SEC source: 0001214659-22-007393 · marketforms-56325.xml · nonDerivative · entry 1

Soffer Rock · CIK 0001845308 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 684,351

F1 · price: The trade was executed in a series of transactions with a price range of $8.05 to $8.09, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Share amounts include 640,098 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

SEC source: 0001214659-22-007229 · marketforms-56223.xml · nonDerivative · entry 1

DS MED LLC · CIK 0001845622 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F2 · price: Shares distributed on a pro rated basis to members of DS Med, LLC, for no consideration.

SEC source: 0001214659-22-007228 · marketforms-56222.xml · nonDerivative · entry 2

Soffer Donald M · CIK 0001845860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,693,737

F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F3 · price: Shares received as part of pro rata distribution by DS Med, LLC, to its members for no consideration.

F4 · balance_after: Amount includes 6,535,223 shares of Class B Common Stock.

SEC source: 0001214659-22-007228 · marketforms-56222.xml · nonDerivative · entry 1

Soffer Donald M · CIK 0001845860 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by affiliate entity

Disclosed balance after: 0

F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F2 · price: Shares distributed on pro rated basis to members of DS Med, LLC, for no consideration.

SEC source: 0001214659-22-007227 · marketforms-56221.xml · nonDerivative · entry 1

Soffer Rock · CIK 0001845308 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 691,851

F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F2 · price: Shares received as part of pro rata distribution by DS Med, LLC, to its members for no consideration.

F3 · balance_after: Amount includes 640,098 shares of Class B Common Stock.

SEC source: 0001214659-22-005522 · marketforms-55996.xml · nonDerivative · entry 2

Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,913,263

F1 · shares: Pursuant to a currently effective Rule 10b5-1 Plan.

F3 · balance_after: Amount includes 7,772,902 shares of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F4 · balance_after: Amount includes 12,936 restricted stock units subject to vesting.

SEC source: 0001214659-22-005522 · marketforms-55996.xml · nonDerivative · entry 1

Hare Joshua · CIK 0001449392 · Director · Chief Scientific Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,913,341

F1 · shares: Pursuant to a currently effective Rule 10b5-1 Plan.

F2 · price: The trade was executed in a series of transactions with a price range of $10.00 to $10.03, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001214659-22-005331 · marketforms-55981.xml · nonDerivative · entry 1

DS MED LLC · CIK 0001845622 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,024,208

F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F2 · price: Shares distributed to members of DS Med, LLC, for no consideration.

F1 · balance_after: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

SEC source: 0001214659-22-005332 · marketforms-55983.xml · nonDerivative · entry 1

Soffer Rock · CIK 0001845308 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,669

F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F2 · price: Shares received as part of distribution by DS Med, LLC, to its members for no consideration.

F3 · balance_after: Amount includes 139,912 shares of Class B Common Stock and 5,000 Restricted Stock Units subject to vesting.

SEC source: 0001214659-22-005396 · marketforms-55982.xml · nonDerivative · entry 1

Soffer Donald M · CIK 0001845860 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by affiliated entity

Disclosed balance after: 7,024,208

F1 · shares: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F3 · shares: Shares held by affiliated entity, for which reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

F2 · price: Shares distributed to members of DS Med, LLC, for no consideration.

F1 · balance_after: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

F3 · balance_after: Shares held by affiliated entity, for which reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

SEC source: 0001214659-22-004906 · marketforms-55973.xml · derivative · entry 4

Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common stock · 50,000 shares

Expires 2032-04-03

F6 · derivative.exercise_date: The option vests ratably 25% each year.

SEC source: 0001214659-22-004906 · marketforms-55973.xml · derivative · entry 3

Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,335

Underlying: Common stock · 2,335 shares

Expires 2032-04-03

F5 · derivative.exercise_date: The option vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.

SEC source: 0001214659-22-004906 · marketforms-55973.xml · nonDerivative · entry 2

Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,335

F3 · shares: Represents the award of 150,000 Restricted Stock Units, which vest ratably 25% each year.

F4 · balance_after: Includes 152,335 Restricted Stock Units.

SEC source: 0001214659-22-004906 · marketforms-55973.xml · nonDerivative · entry 1

Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,335

F1 · shares: Represents the award of 2,335 Restricted Stock Units, which vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.

F2 · balance_after: Includes 2,335 Restricted Stock Units.

SEC source: 0001214659-22-004989 · marketforms-55975.xml · nonDerivative · entry 1

Clavijo James · CIK 0001306908 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,574

F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

SEC source: 0001214659-22-004991 · marketforms-55977.xml · nonDerivative · entry 1

Lehr Paul T · CIK 0001845674 · General Counsel, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,578

F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

SEC source: 0001214659-22-004990 · marketforms-55976.xml · nonDerivative · entry 1

Green Geoff · CIK 0001845416 · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,904

F1 · shares: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

F1 · balance_after: Shares withheld to satisfy the tax obligations in connection with the vesting of a restricted stock unit award.

SEC source: 0001214659-22-005165 · marketforms-55985.xml · derivative · entry 5

Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-04-03

F7 · derivative.exercise_date: The option vests ratably 25% each year.

SEC source: 0001214659-22-005165 · marketforms-55985.xml · derivative · entry 4

Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,335

Underlying: Common Stock · 2,335 shares

Expires 2032-04-03

F6 · derivative.exercise_date: The option vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.

SEC source: 0001214659-22-005165 · marketforms-55985.xml · nonDerivative · entry 3

Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,978

F4 · shares: Represents the award of 150,000 Restricted Stock Units, which vest ratably 25% each year.

F5 · balance_after: Includes 151,978 Restricted Stock Units.

SEC source: 0001214659-22-005165 · marketforms-55985.xml · nonDerivative · entry 2

Min Kwan-Hong Christopher · CIK 0001921798 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,978

F3 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the Restricted Stock Units and does not represent a sale. This Form 4 amendment is being filed solely to report this withholding, which was not reflected in the original Form 4 filed on April 6, 2022.